Evidence map›Paper›PMID 20413552›Full record

ArticleMicrobiology (Reading, England)2010

Reduced synthesis of the Ybt siderophore or production of aberrant Ybt-like molecules activates transcription of yersiniabactin genes in Yersinia pestis.

M Clarke Miller, Jacqueline D Fetherston, Carol L Pickett, Alexander G Bobrov, Robert H Weaver, Edward DeMoll, Robert D Perry

Open access · greenAbstract read
In one paragraph

Article in Microbiology (Reading, England), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Regulatory Functions of PurR inMicroorganisms · 2023
    Article
  5. Article
  6. Overview ofBiology · 2023
    Review
  7. Article
  8. ThemBio · 2022
    Article
  9. Article
  10. Yersiniabactin contributes to overcoming zinc restriction duringProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  11. Extraintestinal PathogenicPathogens (Basel, Switzerland) · 2021
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Beyond iron: non-classical biological functions of bacterial siderophores.Dalton transactions (Cambridge, England : 2003) · 2015
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

M Clarke MillerDepartment of Chemistry, University of Kentucky, Lexington, KY 40506-0055, USA.
Jacqueline D FetherstonDepartment of Microbiology, Immunology, and Molecular Genetics, University of Kentucky, 800 Rose St. MS-415 Medical Center, Lexington, KY 40536-0298, USA.
Carol L PickettDepartment of Microbiology, Immunology, and Molecular Genetics, University of Kentucky, 800 Rose St. MS-415 Medical Center, Lexington, KY 40536-0298, USA.
Alexander G BobrovDepartment of Microbiology, Immunology, and Molecular Genetics, University of Kentucky, 800 Rose St. MS-415 Medical Center, Lexington, KY 40536-0298, USA.
Robert H WeaverDepartment of Microbiology, Immunology, and Molecular Genetics, University of Kentucky, 800 Rose St. MS-415 Medical Center, Lexington, KY 40536-0298, USA.
Edward DeMollDepartment of Biology, 101 T. H. Morgan Building, Lexington, KY 40506-0225, USA.
Robert D PerryDepartment of Microbiology, Immunology, and Molecular Genetics, University of Kentucky, 800 Rose St. MS-415 Medical Center, Lexington, KY 40536-0298, USA.
University of Kentucky · US

Funding

Yersiniabactin and plague pathogenesisR01AI033481 · NIAID · UNIVERSITY OF KENTUCKY · PI PERRY, ROBERT DONALD · 1993 to 2013
$3.6M
Yersiniabactin and plague pathogenesisR56AI033481 · NIAID · UNIVERSITY OF KENTUCKY · PI PERRY, ROBERT DONALD · 2008 to 2008
$366k
NIAID NIH HHS AI033481NIAID NIH HHS R01 AI033481NIAID NIH HHS R56 AI033481
6 · The paper itself

Abstract

Synthesis of the siderophore yersiniabactin (Ybt) proceeds by a mixed nonribosomal peptide synthetase/polyketide synthase mechanism. Transcription of ybt genes encoding biosynthetic and transport functions is repressed under excess iron conditions by Fur, but is also activated by Ybt via the transcriptional regulator YbtA. While mutations in most biosynthetic genes and ybtA negate transcription activation from the regulated promoters, three biosynthetic mutations do not reduce this transcriptional activation. Here we show that two of these mutants, one lacking the putative type II thioesterase (TE) YbtT and the other with a mutation in the TE domain of HMWP1, produce reduced levels of authentic Ybt that are capable of signalling activity. Alanine substitutions in two residues of YbtT that are essential for catalytic activity in other type II TEs reduced the ability of Yersinia pestis to grow under iron-chelated conditions. The third mutant, which lacks the salicylate synthase YbtS, did not make authentic Ybt but did produce a signalling molecule. Finally, a Delta pgm strain of Y. pestis, which lacks essential Ybt biosynthetic genes, also produced a signalling molecule that can activate transcription of ybt genes. The non-Ybt signal molecules from these two mutants are likely separate compounds. While these compounds are not biologically relevant to normal Ybt regulation, a comparison of the structures of Ybt and other signalling molecules will help in determining the chemical structures recognized as a Ybt signal.

Indexed as

Transcriptional ActivationBacterial ProteinsGene Expression Regulation, BacterialPhenolsSiderophoresThiazolesYersinia pestisBacterial ProteinsPhenolsSiderophoresThiazolesyersiniabactin

Identifiers

PMID20413552
PMCPMC3068685
OpenAlexW2037985523

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.